Findings Add to Past Evidence That Early Invasive Procedures Ease Symptoms but Do Not Improve Long-Term Survival. NEW YORK, ...

The drug, Novartis’ pelacarsen, should have worked against lipoprotein(a), a genetic type of cholesterol that causes plaque ...

A Cleveland Clinic-led trial found the drug pelacarsen cut Lp(a) by nearly 80% but did not prevent heart attacks or strokes.

An experimental Novartis drug designed to treat a genetic cause of heart disease failed to reduce deaths and non-fatal heart attacks, dashing hopes for the first of several ​such drugs in clinical ...

Doctors expected an experimental drug that lowers a common risk factor for heart attacks would save patients' lives. The ...

Results are in for a highly anticipated study of an experimental drug meant to reduce major heart events by lowering lipoprotein (a). To the surprise of doctors, the drug didn’t work.

Like cholesterol, inflammation causally contributes to the risk of cardiovascular disease, but findings from the clinical ...

Preliminary new research suggests that cannabis use may raise the risk of cardiovascular disease. The link remained ...

New research suggests aggressive diet and lifestyle changes might actually reverse heart disease in a year—here's what the science really shows about plaque regression and cardiovascular risk.

Most of us measure age in birthdays. That number is your chronological age: the time that has passed since you were born. It ...

Women living in areas with higher estimated indoor radon levels had a greater risk of heart failure after menopause, a large ...